Pharming Group had a return on equity of 4.64% and a net margin of 3.30%. Canaccord Genuity Group began coverage on shares of Pharming Group in a research note on Friday, April 10th. Finally, Wall Street Zen cut Pharming Group from a “strong-buy” rating to a “hold” rating in a report on Saturday, May 9th. Pharming Group Stock Down 18.2%The business has a fifty day moving average of $13.11 and a 200 day moving average of $15.29. Read MoreReceive News & Ratings for Pharming Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharming Group and related companies with MarketBeat.com's FREE daily email newsletter.